AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

McKesson Corporation (MCK)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

597.43

3.74 (0.63%)

At close: Feb 18, 2025, 3:59 PM

599.42

0.33%

After-hours: Feb 18, 2025, 07:00 PM EST

undefined% (undefined)

Bid	583
Market Cap	74.87B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	21.79
PE Ratio (ttm)	27.42
Forward PE	n/a
Analyst	Buy

Ask	600.4
Volume	519,979
Avg. Volume (20D)	755,045
Open	589.54
Previous Close	593.69
Day's Range	585.23 - 598.68
52-Week Range	464.42 - 637.51
Beta	undefined

About MCK

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management,...

[Show more]

Industry Medical - Distribution

Sector Healthcare

IPO Date Nov 10, 1994

Employees 45,000

Stock Exchange NYSE

Ticker Symbol MCK

Website https://www.mckesson.com

Full Company Profile

Analyst Forecast

According to 13 analyst ratings, the average rating for MCK stock is "Buy." The 12-month stock price forecast is $650, which is an increase of 8.80% from the latest price.

Buy 84.62%

Hold 7.69%

Sell 0.00%

Stock Forecasts

Next Earnings Release

McKesson Corporation is scheduled to release its earnings on May 6, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

-1.18%

McKesson shares are trading lower after the compan... Unlock content with Pro Subscription

2 weeks ago

+0.59%

McKesson shares are trading lower after the company reported Q3 financial results and missed its revenue estimate.

News

1 week ago · zacks.com

McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

1 week ago · zacks.com

Should You Buy, Hold or Sell MCK Stock Following Robust Q3 Earnings?

McKesson MCK delivered an 18% increase in revenues ($95.3 billion) and a 16% rise in adjusted operating profit during the third quarter of fiscal 2025 despite ongoing macroeconomic challenges. The com...

1 week ago · zacks.com

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

1 week ago · zacks.com

MCK Stock Down on Q3 Earnings & Sales Miss, Gross Margin Contracts

McKesson's third-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.

1 week ago · seekingalpha.com

McKesson Corporation (MCK) Q3 2025 Earnings Call Transcript

McKesson Corporation. (NYSE:MCK ) Q3 2025 Earnings Conference Call February 5, 2025 4:30 PM ET Company Participants Rachel Rodriguez - VP of Investor Relations Brian Tyler - Chief Executive Officer Br...

1 week ago · zacks.com

Here's What Key Metrics Tell Us About McKesson (MCK) Q3 Earnings

While the top- and bottom-line numbers for McKesson (MCK) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compar...

2 weeks ago · zacks.com

McKesson (MCK) Q3 Earnings and Revenues Miss Estimates

McKesson (MCK) came out with quarterly earnings of $8.03 per share, missing the Zacks Consensus Estimate of $8.04 per share. This compares to earnings of $7.74 per share a year ago.

2 weeks ago · reuters.com

McKesson misses third-quarter revenue estimates

Drug distributor McKesson missed estimates for third-quarter revenue on Wednesday, hurt by less-than-expected sales in its U.S. pharmaceutical segment, which includes branded and specialty drugs.

2 weeks ago · fool.com

McKesson Exceeds EPS, Q3 Profit Surges

Healthcare distribution and services specialist McKesson (MCK 0.59%) reported mixed financial results for fiscal 2025's third quarter on Wednesday, Feb. 5. McKesson beat earnings expectations with an ...

2 weeks ago · businesswire.com

McKesson Corporation Reports Fiscal 2025 Third Quarter Results and Raises Full Year Adjusted EPS Guidance

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2025 third quarter financial results. Results can be accessed on McKesson's Investor Relations website at inves...

Load More News